Prestige Consumer Healthcare, Inc. (PBH)
52.01
+0.70
(+1.36%)
USD |
NYSE |
Aug 24, 16:00
52.01
0.00 (0.00%)
After-Hours: 20:00
Prestige Consumer Healthcare Price to Book Value : 1.285 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 1.268 |
| August 20, 2026 | 1.249 |
| August 19, 2026 | 1.277 |
| August 18, 2026 | 1.250 |
| August 17, 2026 | 1.237 |
| August 14, 2026 | 1.270 |
| August 13, 2026 | 1.268 |
| August 12, 2026 | 1.292 |
| August 11, 2026 | 1.325 |
| August 10, 2026 | 1.310 |
| August 07, 2026 | 1.356 |
| August 06, 2026 | 1.345 |
| August 05, 2026 | 1.309 |
| August 04, 2026 | 1.285 |
| August 03, 2026 | 1.283 |
| July 31, 2026 | 1.241 |
| July 30, 2026 | 1.234 |
| July 29, 2026 | 1.290 |
| July 28, 2026 | 1.278 |
| July 27, 2026 | 1.246 |
| July 24, 2026 | 1.227 |
| July 23, 2026 | 1.210 |
| July 22, 2026 | 1.212 |
| July 21, 2026 | 1.212 |
| July 20, 2026 | 1.246 |
| Date | Value |
|---|---|
| July 17, 2026 | 1.234 |
| July 16, 2026 | 1.251 |
| July 15, 2026 | 1.195 |
| July 14, 2026 | 1.166 |
| July 13, 2026 | 1.207 |
| July 10, 2026 | 1.209 |
| July 09, 2026 | 1.198 |
| July 08, 2026 | 1.194 |
| July 07, 2026 | 1.246 |
| July 06, 2026 | 1.208 |
| July 02, 2026 | 1.221 |
| July 01, 2026 | 1.190 |
| June 30, 2026 | 1.168 |
| June 29, 2026 | 1.204 |
| June 26, 2026 | 1.239 |
| June 25, 2026 | 1.183 |
| June 24, 2026 | 1.186 |
| June 23, 2026 | 1.154 |
| June 22, 2026 | 1.140 |
| June 18, 2026 | 1.178 |
| June 17, 2026 | 1.157 |
| June 16, 2026 | 1.191 |
| June 15, 2026 | 1.17 |
| June 12, 2026 | 1.199 |
| June 11, 2026 | 1.193 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Indivior Pharmaceuticals, Inc. | -- |
| ANI Pharmaceuticals, Inc. | 2.856 |
| Corcept Therapeutics, Inc. | 18.84 |
| Veru, Inc. | 1.568 |
| Johnson & Johnson | 7.739 |
Price to Book Value Related Metrics
| PE Ratio | 14.56 |
| PS Ratio | 2.267 |
| Price to Free Cash Flow | 10.64 |
| Price | 52.01 |
| Earnings Yield | 6.87% |
| Market Cap | 2.464B |
| Operating PE Ratio | 8.632 |
| Normalized PE Ratio | 14.56 |